MGNX Stock Analysis: Buy, Sell, or Hold?
MGNX - MacroGenics, Inc.
$1.83
-0.10 (-5.18%)
▼
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 19, 2026
Get Alerted When MGNX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MGNX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: MGNX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: MGNX is currently trading at $1.83, which is considered extended relative to its 30-day fair value range of $1.60 to $1.79.
Technical Outlook: Technically, MGNX is in a uptrend. Immediate support is located at $1.61, while resistance sits at $1.97. Short-term momentum is weak, with the stock down 5.2% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.40 (+85.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MGNX is in a uptrend. Immediate support is located at $1.61, while resistance sits at $1.97. Short-term momentum is weak, with the stock down 5.2% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.40 (+85.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$1.60 -
$1.79
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
45.8%
Protect Your Profits
Holding MGNX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.2%)
- BULLISH: Trading 85.8% below Wall St target ($3.40)
Fair Price Analysis
30-Day Fair Range
$1.60 -
$1.79
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$1.62
Resistance Level
$1.97
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-1.07
Wall Street Target
$3.40
(+85.8%)
Revenue Growth (YoY)
-34.2%
Earnings Growth (YoY)
-70.4%
Profit Margin
-59.5%
Last updated: February 01, 2026 1:41 PM ET
Data refreshes hourly during market hours. Next update: 2:41 PM
Data refreshes hourly during market hours. Next update: 2:41 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MGNX showing a specific setup today?
Insider Activity (6 Months)
2
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
William K Heiden
BUY
49500 shares
2025-08-20
William K Heiden
BUY
50500 shares
2025-08-19
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 60 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1036 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$85 | 57 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
Advanced MGNX Option Strategies
Professional options setups generated by AI based on today's MGNX price and gamma walls.
